Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively
Idexx Laboratories Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively increased by 0.1% to $10.85M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.5%, from $10.79M to $10.85M. Over 5 years (FY 2020 to FY 2025), Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively shows relatively stable performance with a 0.4% CAGR.
Analysis
How to read this metric
An increase often reflects the issuance of shares for employee compensation or capital raises, while a decrease reflects share buybacks.
Detailed definition
This represents the aggregate par value of all issued and outstanding common shares of the company. It reflects the foun...
Peer comparison
This is a standard line item across all public companies, though the par value per share is often nominal and varies by jurisdiction.
equity_common_stock_valueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.68M | $10.68M | $10.69M | $10.70M | $10.71M | $10.71M | $10.72M | $10.73M | $10.74M | $10.75M | $10.75M | $10.77M | $10.77M | $10.77M | $10.78M | $10.79M | $10.80M | $10.83M | $10.84M | $10.85M |
| QoQ Change | — | +0.1% | +0.1% | +0.1% | +0.1% | +0.0% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.0% | +0.0% | +0.1% | +0.1% | +0.1% | +0.2% | +0.1% | +0.1% |
| YoY Change | — | — | — | — | +0.3% | +0.3% | +0.3% | +0.3% | +0.3% | +0.3% | +0.3% | +0.3% | +0.3% | +0.2% | +0.3% | +0.2% | +0.3% | +0.6% | +0.5% | +0.5% |
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively at Other Companies
Frequently Asked Questions
- What is Idexx Laboratories's common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively?
- Idexx Laboratories (IDXX) reported common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively of $10.85M in Q1 2026.
- How has Idexx Laboratories's common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively changed year-over-year?
- Idexx Laboratories's common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively increased by 0.5% year-over-year, from $10.79M to $10.85M.
- What is the long-term trend for Idexx Laboratories's common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively?
- Over 5 years (2020 to 2025), Idexx Laboratories's common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively has grown at a 0.4% compound annual growth rate (CAGR), from $10.65M to $10.84M.
- What does common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively mean?
- The total par value of all common shares currently held by investors.